• Elevance Health President and CEO Gail Boudreaux disclosed open-market purchases totaling 2,725 common shares at USD 366.41 to USD 368.25.
• Directly held stake rose to 171,976 common shares following the buys.
• An additional 60 common shares were reported as indirectly held in a spouse’s revocable trust.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Elevance Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001287920-26-000006), on July 17, 2026, and is solely responsible for the information contained therein.